Biotechnology Stocks II Performance Guide: Lyell Immunopharma, Inc. (LYEL)
LYEL has no dividends.
Table and Chart of LYEL Performance
See what a $1,000 investment in LYEL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| LYEL Returns | |
|---|---|
| Start Date | Jul-30-2021 |
| Start Price | $14.50 |
| End Date | Jun-17-2024 |
| End Price | $2.17 |
| # Prices | 36 |
| Min Date | Sep-29-2023 |
| Min Price | $1.47 |
| Max Date | Aug-31-2021 |
| Max Price | $15.79 |
| Total Return | -85.03% |
| Annualized Return | -46.91% |
| Current Value of $1,000 Purchase | $150 |
| Number Returns | 630 |
| Average Return | -40.28% |
| Number Profitable Returns | 95 |
| Percent Profitable Returns | 15.08% |
| Number Unprofitable Returns | 535 |
| Percent Unprofitable Returns | 84.92% |
| Profitable to Unprofitable Returns Ratio | 0.18 |
| LYEL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $586,360,000 |
| Beta | -0.404 | Price to Sales | 5,883.30 |
| Earnings per Share | $-0.9000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 1.168 |
| PRICE DATA | |
| 52 Week High | $3.41 |
| 52 Week Low | $1.32 |
| Analyst Target Price | $6.33 |
| 50-Day Moving Average | $2.497 |
| 200-Day Moving Average | $2.083 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $68,000 |
| Profit Margin | 0% |
| Return on Equity | -32.9% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
LYEL Compare Returns with S&P 500
LYEL Trendline Chart
LYEL Moving Average Chart
LYEL Stock Return Map - See Patterns of Gains and Losses
LYEL Stock Returns/Purchase Dates